- Cancer and Blood Diseases (6)
- Diabetes and Endocrinology (5)
- Fetal Care (3)
- Gastroenterology, Hepatology and Nutrition (9)
- Heart (15)
- Mental and Behavioral Health (8)
- Nephrology (2)
- Neurology and Neurosurgery (5)
- Orthopaedics (8)
- Perinatal (2)
- Pulmonary Medicine (6)
- Urology (5)
Search by Keyword
Results (6)
Advancements Bring New Hope for Sickle Cell Disease
A Phase II clinical trial conducted in Ghana suggests that hydroxyurea — already a treatment offered for the most common form of sickle cell disease — also shows benefits for those with the hemoglobin SC (HbSC) variant of the condition.
Advancing Lifesaving Therapies for Myeloid Malignancies
Discover how Cincinnati Children’s is accelerating research and clinical trials to advance therapies for myeloid malignancies across all age groups.
Cincinnati Children’s Adds New Cancer and Blood Disease Faculty
The Cancer and Blood Diseases Institute recently welcomed 10 new faculty members, expanding our solid tumor, leukemia, onco-critical care, bone marrow transplantation, immune deficiency, and hematology programs.
Cincinnati Children’s Launches ENGRAFT Network
ENGRAFT, a new learning health network led by Cincinnati Children’s, brings together pediatric and adult centers to improve transplant and cellular therapy outcomes.
Expanding Expertise with 10 New Faculty in Pediatric Cancer and Blood Disorders
Meet the experts joining the Cancer and Blood Diseases Institute to advance care and research in pediatric oncology, hematology, bone marrow transplantation and proton therapy.
Novel Tests for Pediatric Cancer Diagnosis and Monitoring
Cincinnati Children’s unveils advanced genomic tools for pediatric cancer care—CinCSeq and Histiotrak offer faster, more precise diagnostics and monitoring.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
